↓ Skip to main content

Dove Medical Press

Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants

Overview of attention for article published in Drug Design, Development and Therapy, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
121 Dimensions

Readers on

mendeley
206 Mendeley
citeulike
1 CiteULike
Title
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
Published in
Drug Design, Development and Therapy, January 2015
DOI 10.2147/dddt.s62912
Pubmed ID
Authors

Alan L Pehrson, Connie Sanchez

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Peru 1 <1%
Unknown 205 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 46 22%
Student > Master 29 14%
Student > Bachelor 29 14%
Researcher 17 8%
Student > Doctoral Student 8 4%
Other 25 12%
Unknown 52 25%
Readers by discipline Count As %
Neuroscience 43 21%
Medicine and Dentistry 24 12%
Agricultural and Biological Sciences 22 11%
Biochemistry, Genetics and Molecular Biology 15 7%
Psychology 11 5%
Other 25 12%
Unknown 66 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2023.
All research outputs
#5,410,691
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#358
of 2,296 outputs
Outputs of similar age
#69,763
of 365,327 outputs
Outputs of similar age from Drug Design, Development and Therapy
#11
of 58 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,327 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.